Dott.ssa Astrua Chiara

A.O. Città della Salute e della Scienza di Torino, Le Molinette Presidio San Lazzaro di Torino



ISTRUZIONE E FORMAZIONE

18/07/2011

Laurea in Medicina e Chirurgia presso l'Universita degli Studi di Torino — Molinette


05/07/2012 — 12/07/2017

Scuola di Specialità in Dermatologia e Venereologia presso l'Universita degli Studi di Torino — Molinette


ESPERIENZA PROFESSIONALE

Dal 16/09/2017 a tutt’oggi

Contratto di prestazione d'opera cio SC Dermatologia deII'AOU Cittó della Salute e della Scienza di Torino

PUBBLICAZIONI SCIENTIFICHE

  • Dermatological approach to vemurafenib skin toxicity: a single centre experience. Fava P, Marra E, Astrua C, Brizio M, Cavaliere G, Quaglino P, Fierro MT, Savoia P. G hal Dermatol Venereol. 2014 Oct 9.

 

  • Intestinalinvolvementintoxicepidermalnecrolysis.Acasereportandreviewofliterature. FavaP,AstruaC,CavaliereG,BrizioM,SavoiaP,QuaglinoP,FierroMT.

J Eur Acad Dermatol Venereal. 2014 Apr 23.

 

  • Favourable prognostic role of regression of primary melanoma in AJCC stage I-ll patients. Ribero S, Osella-Abate S, Sanlorenzo M, Savoia P, Astrua C, Cavaliere G, Tomasini C, Senetta R, Macripò G, Bernengo MG, Quaglino P. Br J Dermatol. 2013; 16:1240-5.

 

4)      Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients. Fava P, Astrua C, Chiarugi A, Crocetti E, Pimpinelli N, Fargnoli MC, Maurichi A, Rubegni P, Manganoni AM, Bottoni U, Catricala C, Cavicchini S, Santinami M, Alaibac M, Annetta A, Borghi A, Calzavara Pinton P, Capizzi R, Clerico R, Colombo E, Corradin MT, De Simone P, Fantini F, Ferreli C, Filosa G, Girgenti V, Giulioni E, Guarneri C, Lamberti A, Lisi P, Nardini P, Papini M, Peris K, Pizzichetta MA, Salvini C, Savoia P, Strippoli D, Tolomio E, Tomassini MA, Vena GA, Zichichi L, Patrizi A, Argenziano G, Simonaccì M, Quaglino P. Dermatology. 2015;230: 256-62.

 

  • Complete regression of melanoma skin metastases after elettrochemotherapy plus ipilimumab treatment: an unusual clinical presentation. Brizio M, Fava P, Astrua C et at. EJD 2015.

 

  • Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. Valpione S, Martinoli C, Fava P, Mocellin S, Campana LG, Quaglino P, Ferrucci PF, Pigozzo J, Astrua C, Testori A, Chiarion-Sileni V.Eur J Cancer. 2015 Sep;51(14):2086-94.

 

  • lpilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management. Savoia P, Astrua C, Fava P. Hum Vaccin immunother. 2016 May 3;12(5):1092- 101.
  • Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas. Fava P, Bergallo M, Astrua C, Brizio M, Galliano I, Montanari P, Tovo PA, Novelli M, Savoia P, Quaglino P, Fierro MT. Dermatology. 2016;232(1):38-43.
  • Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma lntergroup. Bruno W, Pastorino L, Ghiorzo P, Andreotti V, Martinuzzi C, Menin C, Elefanti L, Stagni C, Vecchiato A, Rodolfo M, Maurichi A, Manoukian S, De Giorgi V, Savarese I, Gensini F, Borgognoni L, Testori A, Spadola G, Mandalà M, lmberti G, Savoia P, Astrua C, Ronco AM, Farnetti A, Tibiletti MG, Lombardo M, Palmieri G, Ayala F, Ascierto P, Ghigliotti G, Muggianu M, Spagnolo F, Picasso V, Tanda ET, Queirolo P, Bianchi- Scarrà G. J Am Acad Dermatol. 2016 Feb;74(2):325-32.
  • miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL).

Fava P, Bergallo M, Astrua C, Brizio M, Galliano I, Montanari P, Daprà V, Novelli M, Savoia P, Quaglino

^, Fierro MT. J Eur Acad Dermatol Venereol. 2016 3. doi: 10.1111/jdv.13597.

  • Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Filippi AR, Fava P, Badellino S, Astrua C, Ricardi U, Quaglino P.Radiother Oncol. 2016 Jul;120:1-12.
  • A study of melanoma in Eastern European migrants in Italy. Astrua C, Fava P, Brizio M, Savoia P. Eur J Dermatol. 2017 1;27:139-143.
  • Treatment of metastatic melanoma: a multidisciplinary approach. Fava P, Astrua C, Sanlorenzo M, Ribero S, Brizio M, Filippi AR, Marra E, Picciotto F, Sangiolo D, Carnevale-Schianca F, Aglietta M, Sandrucci S, Ricardi U, Caliendo V, Quaglino P, Fierro MT. G ItaI Dermatol Venereol. 2017;152:241-261.
  • Arrhythmias in a patient with metastatic melanoma treated with targeted therapy and implantable cardiovener defibrillator. Licciardello M, Giura MT, Rozzo G, Marra E, Fava P, Astrua C, Contu V, Lista P, Fierro MT, Quaglino P, Ribero S. Br J Dermatol. 2017 Mar 10.
  • Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease. Pileri A, Agostinelli C, Sessa M, Quaglino P, Santucci M, Tomasini C, Grandi V, Fava P, Astrua C, Righi S, Patrizi A, Pileri SA, Pimpinelli N. Virchows Ach. 2017; 470:575-582.